Solvay Shares Drop 2.75% and Approach Key Technical Support
Solvay's stock significantly retreated this Thursday morning, falling 2.75% to 25.50 euros in early trading hours. This decline is part of a broader pullback across European markets, with the CAC 40 dropping 1.64% during the session. The Belgian chemical company's stock is now nearing its technical support level, following a year of continuous deterioration.
Critical Technical Threshold Approached
In this Thursday morning's session, Solvay is trading at 25.50 euros, just cents away from its identified support threshold at 25.46 euros. This level represents a major vigilance zone: a downward breach could pave the way for further decline. The stock is now trading significantly below its 20, 50, and 200-day moving averages, which are positioned at 26.63, 26.61, and 27.59 euros respectively, confirming a bearish trend that has been in place for several months. The RSI, an indicator measuring the momentum of a stock over recent sessions, is at 35, a level that indicates significant selling pressure without yet reaching the oversold zone (below 30). The most relevant resistance is positioned at 28.50 euros, more than 11% above the current price, illustrating the magnitude of the recovery needed for a potential bullish reversal. Over one year, the performance remains poor: the stock has declined by 28.31%, reflecting a significant erosion of the group's market valuation.
General Correction Movement in Europe
This Thursday's session is characterized by a generalized correction movement across Europe. The CAC 40 is down 1.64% at 7,838.95 points, while the SBF 120 has dropped 1.65%. Solvay's decline, more pronounced than that of the indices, also exceeds the falls seen in other major industrial capitalizations listed in Paris. Schneider Electric is down 3.26% and Airbus has fallen 2.81%, but these stocks operate in sectors distinct from specialty chemicals. On the calendar front, the group's next quarterly results are expected on May 7, followed by the annual general meeting scheduled for May 12. These events could provide updated insights into the company's operational and financial trajectory, at a time when the stock suffers from a cumulative decline of 4.78% over three months. The monthly volatility of the stock remains contained at 8.35%, while its nearly zero beta (-0.02) indicates a low historical correlation with overall market movements.
